Skip to content

Clinical trials

Withdrawn Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Withdrawn Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20071
20081
20161
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center1
Novartis Pharmaceuticals1
Shandong University1
University of California, San Francisco1
University of Medicine and Dentistry of New Jersey1
University of Nebraska1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders7
Polycythemia Vera7
Primary Myelofibrosis7
Thrombocythemia, Essential7
Leukemia5
Leukemia, Lymphocytic, Chronic, B-Cell5
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Leukemia, Neutrophilic, Chronic5
Lymphoma5

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.